FDA says breast cancer drug did not extend lives

July 17, 2010 8:45:31 AM PDT
Federal health scientists said Friday that follow-up studies of a Roche breast cancer drug showed that it failed extend patient lives, opening the door for it to be potentially withdrawal for use in treating that disease.